Skip to main content
. 2023 Jun 13;10:1117071. doi: 10.3389/fmed.2023.1117071

Table 2.

Anti-NXP2 and ILD.

Case no Author year Antibody ILD type ILD findings Biopsy PFT Age/Sex Cohort
1. Bermudez et al. (2020) (60) NXP2 NSIP: 1/6 OP: 1/6 Mean FVC: 90% ±14% Mean DLCO: 56% +/−17% Mean age 55 +/− 13 years 5 Female 2 Male France n = 7
2. Gossez et al. (2015) (61) NXP2 Bilateral consolidations lower lung zones 41 years/Female France n = 1